Adaptive Biotechnologies (ADPT) Capital Leases (2019)
Adaptive Biotechnologies (ADPT) posted Capital Leases of $36.6 million for Q4 2019, up 56.11% sequentially from $23.4 million in Q3 2019.
Adaptive Biotechnologies (ADPT) Capital Leases (2019) Analysis & Trends
Adaptive Biotechnologies has reported Capital Leases for 1 years, with the latest figure at $36.6 million in Q4 2019.
- Quarterly Capital Leases changed N/A year-over-year to $36.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $36.6 million (changed N/A YoY) and the FY2019 annual result came in at $36.6 million, changed N/A from the prior year.
- Capital Leases rose to $36.6 million in Q4 2019 per ADPT's latest filing, from $23.4 million in the prior quarter.
- Over five years, Capital Leases peaked at $36.6 million in Q4 2019 and troughed at $23.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 36.61 Mn |
| Sep 30, 2019 | 23.45 Mn |